KIMBERLY CARANO: Open Payments
NPI 1215073796 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,668 in 86 payments from 26 companies in 2025. Trend: 2023 $1,251 · 2024 $1,378 · 2025 $1,668
Food & beverage: $1,668
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 9 | $174 |
| AstraZeneca Pharmaceuticals LP | 7 | $155 |
| Novo Nordisk Inc | 9 | $138 |
| Lilly USA, LLC | 7 | $124 |
| PFIZER INC. | 5 | $111 |
| ABBVIE INC. | 6 | $109 |
| Astellas Pharma US Inc | 4 | $104 |
| Axsome Therapeutics, Inc. | 5 | $94 |
| Amgen Inc. | 5 | $92 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $80 |
Products named: TRELEGY ELLIPTA, NURTEC ODT, Veozah, FARXIGA, EVENITY, MOUNJARO, CAPLYTA, REXULTI.
Industry payments across TN — which companies pay providers there.
